Filter in search result
Total number of binding domains: 227
| Identifier | UniProt Accession | UniProt Gene | UniProt Name | Chromosome | PFAM Domain | Start | End | Database | Cancer Driver | Number of missense mutations | Percent of missense mutation | Number of omim mutations | Percent of omim mutation | Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABL1-201 | P00519 | ABL1 | Tyrosine-protein kinase ABL1 | chr9 | PF07714 | 242 | 493 | Census, Compendium | Yes | 30 | 27.78 % | 1 | 50.00 % | link |
| ABL1-201 | P00519 | ABL1 | Tyrosine-protein kinase ABL1 | chr9 | PF00018 | 67 | 113 | Census, Compendium | Yes | 8 | 7.41 % | 0 | 0.00 % | link |
| ACE-202 | P12821 | ACE | Angiotensin-converting enzyme | chr17 | PF01401 | 643 | 1221 | Not Cancer Driver | No | 86 | 55.48 % | 0 | 0.00 % | link |
| AKT1-218 | P31749 | AKT1 | RAC-alpha serine/threonine-protein kinase | chr14 | PF00433 | 429 | 474 | Census, Compendium | Yes | 2 | 2.02 % | 1 | 25.00 % | link |
| AKT2-206 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | chr19 | PF00069 | 152 | 409 | Census | Yes | 35 | 61.40 % | 1 | 50.00 % | link |
| ANKRA2-201 | Q9H9E1 | ANKRA2 | Ankyrin repeat family A protein 2 | chr5 | PF12796 | 134 | 243 | Not Cancer Driver | No | 12 | 50.00 % | 0 | 0.00 % | link |
| ANPEP-201 | P15144 | ANPEP | Aminopeptidase N | chr15 | PF11838 | 619 | 946 | Not Cancer Driver | No | 35 | 27.56 % | 0 | 0.00 % | link |
| AP1G2-202 | O75843 | AP1G2 | AP-1 complex subunit gamma-like 2 | chr14 | PF02883 | 668 | 780 | Not Cancer Driver | No | 7 | 8.54 % | 0 | 0.00 % | link |
| AP2B1-221 | P63010 | AP2B1 | AP-2 complex subunit beta | chr17 | PF02883 | 711 | 817 | Not Cancer Driver | No | 5 | 6.25 % | 0 | 0.00 % | link |
| AP2B1-221 | P63010 | AP2B1 | AP-2 complex subunit beta | chr17 | PF09066 | 827 | 935 | Not Cancer Driver | No | 9 | 11.25 % | 0 | 0.00 % | link |
| AP4M1-201 | O00189 | AP4M1 | AP-4 complex subunit mu-1 | chr7 | PF00928 | 173 | 453 | Not Cancer Driver | No | 25 | 53.19 % | 0 | 0.00 % | link |
| APBB1-220 | O00213 | APBB1 | Amyloid beta precursor protein binding family B member 1 | chr11 | PF00640 | 543 | 664 | Not Cancer Driver | No | 10 | 12.50 % | 0 | 0.00 % | link |
| APC-201 | P25054 | APC | Adenomatous polyposis coli protein | chr5 | PF00514 | 649 | 689 | Census, Compendium | Yes | 3 | 1.02 % | 0 | 0.00 % | link |
| AR-201 | P10275 | AR | Androgen receptor | chrX | PF00104 | 690 | 881 | Census, Compendium | Yes | 35 | 30.17 % | 89 | 61.81 % | link |
| ATG12-208 | O94817 | ATG12 | Ubiquitin-like protein ATG12 | chr5 | PF04110 | 54 | 140 | Not Cancer Driver | No | 7 | 53.85 % | 0 | 0.00 % | link |
| ATG5-204 | Q9H1Y0 | ATG5 | Autophagy protein 5 | chr6 | PF04106 | 79 | 270 | Not Cancer Driver | No | 30 | 90.91 % | 1 | 100.00 % | link |
| BAIAP2-202 | Q9UQB8 | BAIAP2 | Brain-specific angiogenesis inhibitor 1-associated protein 2 | chr17 | PF08397 | 17 | 237 | Not Cancer Driver | No | 18 | 29.51 % | 0 | 0.00 % | link |
| BAX-202 | Q07812 | BAX | Apoptosis regulator BAX | chr19 | PF00452 | 63 | 158 | Census | Yes | 22 | 91.67 % | 0 | 0.00 % | link |
| BCL2A1-201 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | chr15 | PF00452 | 37 | 140 | Not Cancer Driver | No | 11 | 61.11 % | 0 | 0.00 % | link |
| BCL2L1-201 | Q07817 | BCL2L1 | Bcl-2-like protein 1 | chr20 | PF02180 | 1 | 26 | Not Cancer Driver | No | 1 | 4.55 % | 0 | 0.00 % | link |
| BCL2L1-201 | Q07817 | BCL2L1 | Bcl-2-like protein 1 | chr20 | PF00452 | 90 | 188 | Not Cancer Driver | No | 9 | 40.91 % | 0 | 0.00 % | link |
| BCL2L2-201 | Q92843 | BCL2L2 | Bcl-2-like protein 2 | chr14 | PF02180 | 6 | 31 | Not Cancer Driver | No | 0 | 0.00 % | 0 | 0.00 % | link |
| BCL6-202 | P41182 | BCL6 | B-cell lymphoma 6 protein | chr3 | PF00651 | 22 | 129 | Census, Compendium | Yes | 10 | 10.99 % | 0 | 0.00 % | link |
| BIRC2-201 | Q13490 | BIRC2 | Baculoviral IAP repeat-containing protein 2 | chr11 | PF00653 | 272 | 337 | Not Cancer Driver | No | 8 | 16.33 % | 0 | 0.00 % | link |
| BIRC5-202 | O15392 | BIRC5 | Baculoviral IAP repeat-containing protein 5 | chr17 | PF00653 | 18 | 88 | Not Cancer Driver | No | 6 | 37.50 % | 0 | 0.00 % | link |
| C3-201 | P01024 | C3 | Complement C3 | chr19 | PF01835 | 129 | 224 | Not Cancer Driver | No | 16 | 6.20 % | 1 | 9.09 % | link |
| C8G-201 | P07360 | C8G | Complement component C8 gamma chain | chr9 | PF00061 | 48 | 186 | Not Cancer Driver | No | 8 | 88.89 % | 0 | 0.00 % | link |
| CASP7-203 | P55210 | CASP7 | Caspase-7 | chr10 | PF00656 | 68 | 301 | Not Cancer Driver | No | 23 | 82.14 % | 0 | 0.00 % | link |
| CBX1-201 | P83916 | CBX1 | Chromobox protein homolog 1 | chr17 | PF01393 | 118 | 170 | Not Cancer Driver | No | 7 | 41.18 % | 0 | 0.00 % | link |
| CBX3-202 | Q13185 | CBX3 | Chromobox protein homolog 3 | chr7 | PF00385 | 30 | 79 | Not Cancer Driver | No | 6 | 33.33 % | 0 | 0.00 % | link |
| CCNA2-201 | P20248 | CCNA2 | Cyclin-A2 | chr4 | PF02984 | 309 | 427 | Not Cancer Driver | No | 12 | 35.29 % | 0 | 0.00 % | link |
| CCNA2-201 | P20248 | CCNA2 | Cyclin-A2 | chr4 | PF00134 | 181 | 307 | Not Cancer Driver | No | 7 | 20.59 % | 0 | 0.00 % | link |
| CCNT1-201 | O60563 | CCNT1 | Cyclin-T1 | chr12 | PF00134 | 10 | 149 | Not Cancer Driver | No | 14 | 21.54 % | 0 | 0.00 % | link |
| CDC20-201 | Q12834 | CDC20 | Cell division cycle protein 20 homolog | chr1 | PF12894 | 218 | 279 | Not Cancer Driver | No | 5 | 13.89 % | 0 | 0.00 % | link |
| CDK2-201 | P24941 | CDK2 | Cyclin-dependent kinase 2 | chr12 | PF00069 | 4 | 286 | Not Cancer Driver | No | 16 | 94.12 % | 0 | 0.00 % | link |
| CEP55-201 | Q53EZ4 | CEP55 | Centrosomal protein of 55 kDa | chr10 | PF12180 | 171 | 204 | Not Cancer Driver | No | 2 | 5.88 % | 0 | 0.00 % | link |
| CETN2-201 | P41208 | CETN2 | Centrin-2 | chrX | PF13499 | 103 | 167 | Not Cancer Driver | No | 7 | 41.18 % | 0 | 0.00 % | link |
| CHEK1-204 | O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | chr11 | PF00069 | 9 | 265 | Not Cancer Driver | No | 22 | 52.38 % | 0 | 0.00 % | link |
| CLIP1-219 | P30622 | CLIP1 | CAP-Gly domain-containing linker protein 1 | chr12 | PF01302 | 214 | 278 | Census, Compendium | Yes | 9 | 9.18 % | 0 | 0.00 % | link |
| CREBBP-201 | Q92793 | CREBBP | CREB-binding protein | chr16 | PF00439 | 1094 | 1180 | Census, Compendium | Yes | 12 | 5.50 % | 1 | 3.33 % | link |
| CTNNB1-201 | P35222 | CTNNB1 | Catenin beta-1 | chr3 | PF00514 | 583 | 623 | Census, Compendium | Yes | 8 | 2.20 % | 0 | 0.00 % | link |
| CTNND1-205 | O60716 | CTNND1 | Catenin delta-1 | chr11 | PF00514 | 701 | 739 | Census | Yes | 5 | 4.63 % | 0 | 0.00 % | link |
| CTTN-201 | Q14247 | CTTN | Src substrate cortactin | chr11 | PF14604 | 499 | 547 | Not Cancer Driver | No | 13 | 23.64 % | 0 | 0.00 % | link |
| DCTN1-226 | Q14203 | DCTN1 | Dynactin subunit 1 | chr2 | PF01302 | 29 | 94 | Census | Yes | 6 | 4.65 % | 6 | 66.67 % | link |
| DCUN1D3-201 | Q8IWE4 | DCUN1D3 | DCN1-like protein 3 | chr16 | PF03556 | 162 | 276 | Not Cancer Driver | No | 14 | 42.42 % | 0 | 0.00 % | link |
| DDX6-206 | P26196 | DDX6 | Probable ATP-dependent RNA helicase DDX6 | chr11 | PF00271 | 320 | 429 | Census, Compendium | Yes | 10 | 34.48 % | 4 | 100.00 % | link |
| DLG1-269 | Q12959 | DLG1 | Disks large homolog 1 | chr3 | PF00595 | 466 | 544 | Not Cancer Driver | No | 5 | 5.62 % | 0 | 0.00 % | link |
| DNAJB1-201 | P25685 | DNAJB1 | DnaJ homolog subfamily B member 1 | chr19 | PF01556 | 164 | 323 | Census, Compendium | Yes | 11 | 42.31 % | 0 | 0.00 % | link |
| DNMBP-201 | Q6XZF7 | DNMBP | Dynamin-binding protein | chr10 | PF00018 | 1519 | 1568 | Not Cancer Driver | No | 5 | 3.57 % | 0 | 0.00 % | link |
| DPP3-209 | Q9NY33 | DPP3 | Dipeptidyl peptidase 3 | chr11 | PF03571 | 143 | 704 | Not Cancer Driver | No | 68 | 76.40 % | 0 | 0.00 % | link |
| DPP4-201 | P27487 | DPP4 | Dipeptidyl peptidase 4 | chr2 | PF00326 | 559 | 765 | Not Cancer Driver | No | 34 | 31.48 % | 0 | 0.00 % | link |
| DPY30-202 | Q9C005 | DPY30 | Protein dpy-30 homolog | chr2 | PF05186 | 52 | 93 | Not Cancer Driver | No | 4 | 57.14 % | 0 | 0.00 % | link |
| DYNLL1-201 | P63167 | DYNLL1 | Dynein light chain 1, cytoplasmic | chr12 | PF01221 | 5 | 88 | Not Cancer Driver | No | 7 | 87.50 % | 0 | 0.00 % | link |
| DYNLL2-201 | Q96FJ2 | DYNLL2 | Dynein light chain 2, cytoplasmic | chr17 | PF01221 | 5 | 88 | Not Cancer Driver | No | 5 | 100.00 % | 0 | 0.00 % | link |
| EGFR-201 | P00533 | EGFR | Epidermal growth factor receptor | chr7 | PF01030 | 361 | 481 | Census, Compendium | Yes | 23 | 6.63 % | 1 | 100.00 % | link |
| EGFR-201 | P00533 | EGFR | Epidermal growth factor receptor | chr7 | PF00757 | 177 | 338 | Census, Compendium | Yes | 103 | 29.68 % | 0 | 0.00 % | link |
| EGLN1-201 | Q9GZT9 | EGLN1 | Egl nine homolog 1 | chr1 | PF13640 | 298 | 391 | Not Cancer Driver | No | 5 | 22.73 % | 2 | 100.00 % | link |
| EIF4E-203 | P06730 | EIF4E | Eukaryotic translation initiation factor 4E | chr4 | PF01652 | 38 | 197 | Not Cancer Driver | No | 14 | 77.78 % | 0 | 0.00 % | link |
| ENST00000558468 | Q96EP0 | RNF31 | E3 ubiquitin-protein ligase RNF31 | chr14 | PF09409 | 69 | 150 | Not Cancer Driver | No | 7 | 6.03 % | 0 | 0.00 % | link |
| EPB41L3-201 | Q9Y2J2 | EPB41L3 | Band 4.1-like protein 3 | chr18 | PF09379 | 114 | 177 | Not Cancer Driver | No | 11 | 4.58 % | 0 | 0.00 % | link |
| EPHA4-201 | P54764 | EPHA4 | Ephrin type-A receptor 4 | chr2 | PF01404 | 31 | 204 | Not Cancer Driver | No | 24 | 18.18 % | 0 | 0.00 % | link |
| ERAP2-202 | Q6P179 | ERAP2 | Endoplasmic reticulum aminopeptidase 2 | chr5 | PF01433 | 298 | 541 | Not Cancer Driver | No | 23 | 31.51 % | 0 | 0.00 % | link |
| ERBIN-201 | Q96RT1 | ERBIN | Erbin | chr5 | PF00595 | 1321 | 1407 | Not Cancer Driver | No | 6 | 5.31 % | 0 | 0.00 % | link |
| ESR1-201 | P03372 | ESR1 | Estrogen receptor | chr6 | PF00104 | 332 | 531 | Census, Compendium | Yes | 30 | 32.61 % | 2 | 100.00 % | link |
| ESR2-202 | Q92731 | ESR2 | Estrogen receptor beta | chr14 | PF00104 | 283 | 482 | Not Cancer Driver | No | 19 | 27.54 % | 1 | 100.00 % | link |
| ESRRA-201 | P11474 | ESRRA | Steroid hormone receptor ERR1 | chr11 | PF00104 | 224 | 404 | Compendium | Yes | 7 | 25.93 % | 0 | 0.00 % | link |
| ESRRG-209 | P62508 | ESRRG | Estrogen-related receptor gamma | chr1 | PF00104 | 255 | 441 | Not Cancer Driver | No | 46 | 41.07 % | 0 | 0.00 % | link |
| F11-202 | P03951 | F11 | Coagulation factor XI | chr4 | PF00089 | 388 | 618 | Not Cancer Driver | No | 24 | 28.24 % | 24 | 42.11 % | link |
| F2-201 | P00734 | F2 | Prothrombin | chr11 | PF00089 | 364 | 613 | Not Cancer Driver | No | 29 | 34.12 % | 6 | 66.67 % | link |
| FLNA-202 | P21333 | FLNA | Filamin-A | chrX | PF00630 | 2554 | 2643 | Census | Yes | 12 | 3.81 % | 0 | 0.00 % | link |
| FN1-203 | P02751 | FN1 | Fibronectin | chr2 | PF00039 | 2386 | 2421 | Compendium | Yes | 7 | 2.40 % | 0 | 0.00 % | link |
| FYN-202 | P06241 | FYN | Tyrosine-protein kinase Fyn | chr6 | PF00018 | 88 | 135 | Not Cancer Driver | No | 7 | 10.94 % | 0 | 0.00 % | link |
| GABARAP-201 | O95166 | GABARAP | Gamma-aminobutyric acid receptor-associated protein | chr17 | PF02991 | 13 | 116 | Not Cancer Driver | No | 7 | 100.00 % | 0 | 0.00 % | link |
| GALNT2-201 | Q10471 | GALNT2 | Polypeptide N-acetylgalactosaminyltransferase 2 | chr1 | PF00652 | 446 | 563 | Not Cancer Driver | No | 15 | 21.43 % | 0 | 0.00 % | link |
| GALNT2-201 | Q10471 | GALNT2 | Polypeptide N-acetylgalactosaminyltransferase 2 | chr1 | PF00535 | 139 | 322 | Not Cancer Driver | No | 28 | 40.00 % | 1 | 50.00 % | link |
| GEMIN2-202 | O14893 | GEMIN2 | Gem-associated protein 2 | chr14 | PF04938 | 37 | 273 | Not Cancer Driver | No | 14 | 82.35 % | 0 | 0.00 % | link |
| GGA1-203 | Q9UJY5 | GGA1 | ADP-ribosylation factor-binding protein GGA1 | chr22 | PF00790 | 5 | 143 | Not Cancer Driver | No | 12 | 21.05 % | 0 | 0.00 % | link |
| GGA1-203 | Q9UJY5 | GGA1 | ADP-ribosylation factor-binding protein GGA1 | chr22 | PF02883 | 513 | 631 | Not Cancer Driver | No | 14 | 24.56 % | 0 | 0.00 % | link |
| GGA3-201 | Q9NZ52 | GGA3 | ADP-ribosylation factor-binding protein GGA3 | chr17 | PF00790 | 3 | 142 | Not Cancer Driver | No | 10 | 19.61 % | 0 | 0.00 % | link |
| GOPC-202 | Q9HD26 | GOPC | Golgi-associated PDZ and coiled-coil motif-containing protein | chr6 | PF00595 | 288 | 368 | Census | Yes | 8 | 20.00 % | 0 | 0.00 % | link |
| GORASP1-201 | Q9BQQ3 | GORASP1 | Golgi reassembly-stacking protein 1 | chr3 | PF04495 | 69 | 205 | Not Cancer Driver | No | 14 | 41.18 % | 0 | 0.00 % | link |
| GP1BA-201 | P07359 | GP1BA | Platelet glycoprotein Ib alpha chain | chr17 | PF13855 | 116 | 174 | Not Cancer Driver | No | 6 | 18.18 % | 3 | 37.50 % | link |
| GPSM2-201 | P81274 | GPSM2 | G-protein-signaling modulator 2 | chr1 | PF13176 | 204 | 239 | Not Cancer Driver | No | 0 | 0.00 % | 0 | 0.00 % | link |
| GRB7-201 | Q14451 | GRB7 | Growth factor receptor-bound protein 7 | chr17 | PF00017 | 431 | 512 | Not Cancer Driver | No | 7 | 11.48 % | 0 | 0.00 % | link |
| GSK3B-201 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | chr3 | PF00069 | 56 | 340 | Not Cancer Driver | No | 29 | 85.29 % | 0 | 0.00 % | link |
| GZMH-201 | P20718 | GZMH | Granzyme H | chr14 | PF00089 | 21 | 239 | Not Cancer Driver | No | 30 | 88.24 % | 0 | 0.00 % | link |
| GZMM-201 | P51124 | GZMM | Granzyme M | chr19 | PF00089 | 26 | 249 | Not Cancer Driver | No | 21 | 87.50 % | 0 | 0.00 % | link |
| HAT1-201 | O14929 | HAT1 | Histone acetyltransferase type B catalytic subunit | chr2 | PF10394 | 25 | 187 | Not Cancer Driver | No | 9 | 27.27 % | 0 | 0.00 % | link |
| HGFAC-201 | Q04756 | HGFAC | Hepatocyte growth factor activator | chr4 | PF00089 | 408 | 641 | Not Cancer Driver | No | 28 | 38.89 % | 0 | 0.00 % | link |
| HIF1AN-201 | Q9NWT6 | HIF1AN | Hypoxia-inducible factor 1-alpha inhibitor | chr10 | PF13621 | 48 | 302 | Not Cancer Driver | No | 22 | 91.67 % | 0 | 0.00 % | link |
| HLA-B-249 | P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | chr6 | PF07654 | 211 | 290 | Compendium | Yes | 22 | 44.90 % | 0 | 0.00 % | link |
| HLA-B-249 | P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | chr6 | PF00129 | 25 | 203 | Compendium | Yes | 13 | 26.53 % | 0 | 0.00 % | link |
| HLA-E-201 | P13747 | HLA-E | HLA class I histocompatibility antigen, alpha chain E | chr6 | PF07654 | 207 | 287 | Not Cancer Driver | No | 14 | 35.00 % | 0 | 0.00 % | link |
| HLA-E-201 | P13747 | HLA-E | HLA class I histocompatibility antigen, alpha chain E | chr6 | PF00129 | 22 | 200 | Not Cancer Driver | No | 15 | 37.50 % | 0 | 0.00 % | link |
| HLA-G-201 | P17693 | HLA-G | HLA class I histocompatibility antigen, alpha chain G | chr6 | PF00129 | 25 | 203 | Not Cancer Driver | No | 21 | 40.38 % | 0 | 0.00 % | link |
| HLA-G-201 | P17693 | HLA-G | HLA class I histocompatibility antigen, alpha chain G | chr6 | PF07654 | 211 | 290 | Not Cancer Driver | No | 18 | 34.62 % | 0 | 0.00 % | link |
| HNF4A-201 | P41235 | HNF4A | Hepatocyte nuclear factor 4-alpha | chr20 | PF00104 | 172 | 361 | Not Cancer Driver | No | 35 | 30.97 % | 1 | 20.00 % | link |
| IGF1R-217 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | chr15 | PF07714 | 999 | 1266 | Not Cancer Driver | No | 22 | 15.38 % | 1 | 16.67 % | link |
| INSR-201 | P06213 | INSR | Insulin receptor | chr19 | PF07714 | 1023 | 1290 | Not Cancer Driver | No | 35 | 25.18 % | 19 | 30.16 % | link |
| INTS3-201 | Q68E01 | INTS3 | Integrator complex subunit 3 | chr1 | PF10189 | 271 | 495 | Not Cancer Driver | No | 20 | 21.98 % | 0 | 0.00 % | link |
| ITCH-201 | Q96J02 | ITCH | E3 ubiquitin-protein ligase Itchy homolog | chr20 | PF00397 | 480 | 509 | Not Cancer Driver | No | 1 | 1.33 % | 0 | 0.00 % | link |
| KAT6A-201 | Q92794 | KAT6A | Histone acetyltransferase KAT6A | chr8 | PF00628 | 264 | 313 | Census, Compendium | Yes | 3 | 2.52 % | 0 | 0.00 % | link |
| KDM1B-205 | Q8NB78 | KDM1B | Lysine-specific histone demethylase 2 | chr6 | PF03486 | 355 | 635 | Not Cancer Driver | No | 19 | 32.76 % | 0 | 0.00 % | link |
| KDM1B-205 | Q8NB78 | KDM1B | Lysine-specific histone demethylase 2 | chr6 | PF07992 | 355 | 635 | Not Cancer Driver | No | 19 | 32.76 % | 0 | 0.00 % | link |
| KLHL2-201 | O95198 | KLHL2 | Kelch-like protein 2 | chr4 | PF01344 | 532 | 577 | Not Cancer Driver | No | 7 | 12.96 % | 0 | 0.00 % | link |
| KLHL3-201 | Q9UH77 | KLHL3 | Kelch-like protein 3 | chr5 | PF01344 | 526 | 571 | Not Cancer Driver | No | 4 | 7.41 % | 4 | 13.79 % | link |
| KLK4-201 | Q9Y5K2 | KLK4 | Kallikrein-4 | chr19 | PF00089 | 31 | 247 | Not Cancer Driver | No | 37 | 97.37 % | 0 | 0.00 % | link |
| KPNA2-201 | P52292 | KPNA2 | Importin subunit alpha-1 | chr17 | PF00514 | 409 | 448 | Not Cancer Driver | No | 3 | 5.45 % | 0 | 0.00 % | link |
| KPNB1-201 | Q14974 | KPNB1 | Importin subunit beta-1 | chr17 | PF03810 | 21 | 101 | Not Cancer Driver | No | 6 | 7.59 % | 0 | 0.00 % | link |
| KRIT1-203 | O00522 | KRIT1 | Krev interaction trapped protein 1 | chr7 | PF00373 | 517 | 640 | Not Cancer Driver | No | 8 | 12.31 % | 1 | 50.00 % | link |
| LCN2-201 | P80188 | LCN2 | Neutrophil gelatinase-associated lipocalin | chr9 | PF00061 | 48 | 193 | Not Cancer Driver | No | 10 | 50.00 % | 0 | 0.00 % | link |
| LGALS8-206 | O00214 | LGALS8 | Galectin-8 | chr1 | PF00337 | 186 | 316 | Not Cancer Driver | No | 11 | 36.67 % | 0 | 0.00 % | link |
| LIG4-202 | P49917 | LIG4 | DNA ligase 4 | chr13 | PF04675 | 15 | 208 | Not Cancer Driver | No | 13 | 12.62 % | 0 | 0.00 % | link |
| LRP6-201 | O75581 | LRP6 | Low-density lipoprotein receptor-related protein 6 | chr12 | PF14670 | 893 | 929 | Not Cancer Driver | No | 1 | 0.68 % | 0 | 0.00 % | link |
| MAD2L1-201 | Q13257 | MAD2L1 | Mitotic spindle assembly checkpoint protein MAD2A | chr4 | PF02301 | 16 | 196 | Not Cancer Driver | No | 15 | 71.43 % | 0 | 0.00 % | link |
| MAD2L2-207 | Q9UI95 | MAD2L2 | Mitotic spindle assembly checkpoint protein MAD2B | chr1 | PF02301 | 16 | 135 | Not Cancer Driver | No | 6 | 37.50 % | 1 | 100.00 % | link |
| MAPK1-201 | P28482 | MAPK1 | Mitogen-activated protein kinase 1 | chr22 | PF00069 | 25 | 313 | Census, Compendium | Yes | 28 | 53.85 % | 3 | 50.00 % | link |
| MAPK10-319 | P53779 | MAPK10 | Mitogen-activated protein kinase 10 | chr4 | PF00069 | 64 | 359 | Not Cancer Driver | No | 52 | 72.22 % | 0 | 0.00 % | link |
| MAPK14-201 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | chr6 | PF00069 | 24 | 308 | Not Cancer Driver | No | 21 | 95.45 % | 0 | 0.00 % | link |
| MAPK8-206 | P45983 | MAPK8 | Mitogen-activated protein kinase 8 | chr10 | PF00069 | 26 | 321 | Not Cancer Driver | No | 40 | 76.92 % | 0 | 0.00 % | link |
| MAPRE1-201 | Q15691 | MAPRE1 | Microtubule-associated protein RP/EB family member 1 | chr20 | PF03271 | 210 | 248 | Not Cancer Driver | No | 1 | 5.88 % | 0 | 0.00 % | link |
| MARK2-204 | Q7KZI7 | MARK2 | Serine/threonine-protein kinase MARK2 | chr11 | PF00627 | 324 | 360 | Compendium | Yes | 4 | 4.76 % | 0 | 0.00 % | link |
| MASP2-201 | O00187 | MASP2 | Mannan-binding lectin serine protease 2 | chr1 | PF00089 | 445 | 679 | Not Cancer Driver | No | 20 | 25.64 % | 0 | 0.00 % | link |
| MCL1-202 | Q07820 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | chr1 | PF00452 | 213 | 312 | Not Cancer Driver | No | 10 | 37.04 % | 0 | 0.00 % | link |
| MDM2-224 | Q00987 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | chr12 | PF02201 | 26 | 101 | Census, Compendium | Yes | 4 | 10.26 % | 0 | 0.00 % | link |
| MDM4-203 | O15151 | MDM4 | Protein Mdm4 | chr1 | PF02201 | 25 | 95 | Census, Compendium | Yes | 4 | 12.12 % | 0 | 0.00 % | link |
| MOB1A-201 | Q9H8S9 | MOB1A | MOB kinase activator 1A | chr2 | PF03637 | 33 | 204 | Not Cancer Driver | No | 12 | 100.00 % | 0 | 0.00 % | link |
| NAA40-202 | Q86UY6 | NAA40 | N-alpha-acetyltransferase 40 | chr11 | PF00583 | 71 | 192 | Not Cancer Driver | No | 8 | 47.06 % | 0 | 0.00 % | link |
| NCF1-201 | P14598 | NCF1 | Neutrophil cytosol factor 1 | chr7 | PF00018 | 232 | 277 | Not Cancer Driver | No | 0 | 0.00 % | 0 | 0.00 % | link |
| NPR3-201 | P17342 | NPR3 | Atrial natriuretic peptide receptor 3 | chr5 | PF01094 | 71 | 425 | Not Cancer Driver | No | 64 | 81.01 % | 2 | 100.00 % | link |
| NR1H2-201 | P55055 | NR1H2 | Oxysterols receptor LXR-beta | chr19 | PF00104 | 256 | 444 | Not Cancer Driver | No | 13 | 34.21 % | 0 | 0.00 % | link |
| NR1H3-211 | Q13133 | NR1H3 | Oxysterols receptor LXR-alpha | chr11 | PF00104 | 243 | 431 | Not Cancer Driver | No | 14 | 31.82 % | 0 | 0.00 % | link |
| NR1H4-209 | Q96RI1 | NR1H4 | Bile acid receptor | chr12 | PF00104 | 289 | 471 | Not Cancer Driver | No | 21 | 25.61 % | 0 | 0.00 % | link |
| NR1I2-202 | O75469 | NR1I2 | Nuclear receptor subfamily 1 group I member 2 | chr3 | PF00104 | 238 | 415 | Not Cancer Driver | No | 15 | 33.33 % | 0 | 0.00 % | link |
| NR3C1-203 | P04150 | NR3C1 | Glucocorticoid receptor | chr5 | PF00104 | 549 | 741 | Not Cancer Driver | No | 15 | 27.27 % | 7 | 63.64 % | link |
| NR3C2-203 | P08235 | NR3C2 | Mineralocorticoid receptor | chr4 | PF00104 | 757 | 946 | Not Cancer Driver | No | 20 | 16.67 % | 9 | 64.29 % | link |
| NR5A1-202 | Q13285 | NR5A1 | Steroidogenic factor 1 | chr9 | PF00104 | 250 | 442 | Not Cancer Driver | No | 14 | 33.33 % | 3 | 13.04 % | link |
| NR5A2-203 | O00482 | NR5A2 | Nuclear receptor subfamily 5 group A member 2 | chr1 | PF00104 | 330 | 523 | Not Cancer Driver | No | 34 | 34.00 % | 0 | 0.00 % | link |
| OGT-202 | O15294 | OGT | UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit | chrX | PF13844 | 476 | 1016 | Not Cancer Driver | No | 64 | 57.66 % | 0 | 0.00 % | link |
| OGT-202 | O15294 | OGT | UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit | chrX | PF13414 | 436 | 474 | Not Cancer Driver | No | 4 | 3.60 % | 0 | 0.00 % | link |
| OXSR1-201 | O95747 | OXSR1 | Serine/threonine-protein kinase OSR1 | chr3 | PF12202 | 434 | 491 | Not Cancer Driver | No | 9 | 17.65 % | 0 | 0.00 % | link |
| PABPC1-201 | P11940 | PABPC1 | Polyadenylate-binding protein 1 | chr8 | PF00658 | 547 | 614 | Census, Compendium | Yes | 5 | 9.43 % | 0 | 0.00 % | link |
| PADI4-201 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | chr1 | PF03068 | 283 | 660 | Not Cancer Driver | No | 66 | 67.35 % | 0 | 0.00 % | link |
| PADI4-201 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | chr1 | PF08526 | 1 | 111 | Not Cancer Driver | No | 17 | 17.35 % | 0 | 0.00 % | link |
| PADI4-201 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | chr1 | PF08527 | 113 | 273 | Not Cancer Driver | No | 14 | 14.29 % | 0 | 0.00 % | link |
| PAK4-203 | O96013 | PAK4 | Serine/threonine-protein kinase PAK 4 | chr19 | PF00069 | 321 | 572 | Not Cancer Driver | No | 17 | 36.96 % | 0 | 0.00 % | link |
| PCID2-202 | Q5JVF3 | PCID2 | PCI domain-containing protein 2 | chr13 | PF01399 | 277 | 388 | Not Cancer Driver | No | 6 | 17.65 % | 0 | 0.00 % | link |
| PCNA-201 | P12004 | PCNA | Proliferating cell nuclear antigen | chr20 | PF00705 | 1 | 125 | Not Cancer Driver | No | 8 | 42.11 % | 0 | 0.00 % | link |
| PCNA-201 | P12004 | PCNA | Proliferating cell nuclear antigen | chr20 | PF02747 | 127 | 254 | Not Cancer Driver | No | 11 | 57.89 % | 1 | 100.00 % | link |
| PDCD10-201 | Q9BUL8 | PDCD10 | Programmed cell death protein 10 | chr3 | PF06840 | 14 | 161 | Not Cancer Driver | No | 19 | 76.00 % | 0 | 0.00 % | link |
| PDCD6-201 | O75340 | PDCD6 | Programmed cell death protein 6 | chr5 | PF13499 | 92 | 156 | Not Cancer Driver | No | 7 | 43.75 % | 0 | 0.00 % | link |
| PDCD6-201 | O75340 | PDCD6 | Programmed cell death protein 6 | chr5 | PF13202 | 30 | 53 | Not Cancer Driver | No | 3 | 18.75 % | 0 | 0.00 % | link |
| PDCD6IP-201 | Q8WUM4 | PDCD6IP | Programmed cell death 6-interacting protein | chr3 | PF03097 | 4 | 378 | Not Cancer Driver | No | 28 | 48.28 % | 0 | 0.00 % | link |
| PDPK1-202 | O15530 | PDPK1 | 3-phosphoinositide-dependent protein kinase 1 | chr16 | PF00069 | 82 | 342 | Not Cancer Driver | No | 3 | 13.04 % | 0 | 0.00 % | link |
| PEX3-201 | P56589 | PEX3 | Peroxisomal biogenesis factor 3 | chr6 | PF04882 | 94 | 364 | Not Cancer Driver | No | 15 | 83.33 % | 2 | 100.00 % | link |
| PEX5-221 | P50542 | PEX5 | Peroxisomal targeting signal 1 receptor | chr12 | PF13181 | 556 | 589 | Not Cancer Driver | No | 5 | 9.62 % | 0 | 0.00 % | link |
| PFN1-201 | P07737 | PFN1 | Profilin-1 | chr17 | PF00235 | 2 | 140 | Not Cancer Driver | No | 13 | 100.00 % | 3 | 100.00 % | link |
| PGC-202 | P20142 | PGC | Gastricsin | chr6 | PF00026 | 72 | 387 | Not Cancer Driver | No | 36 | 73.47 % | 0 | 0.00 % | link |
| PGR-202 | P06401 | PGR | Progesterone receptor | chr11 | PF00104 | 704 | 891 | Not Cancer Driver | No | 39 | 28.68 % | 0 | 0.00 % | link |
| PIM1-201 | P11309 | PIM1 | Serine/threonine-protein kinase pim-1 | chr6 | PF00069 | 38 | 290 | Census, Compendium | Yes | 47 | 77.05 % | 0 | 0.00 % | link |
| PLAU-201 | P00749 | PLAU | Urokinase-type plasminogen activator | chr10 | PF00089 | 179 | 419 | Not Cancer Driver | No | 28 | 54.90 % | 0 | 0.00 % | link |
| PPARA-202 | Q07869 | PPARA | Peroxisome proliferator-activated receptor alpha | chr22 | PF00104 | 264 | 449 | Not Cancer Driver | No | 16 | 32.65 % | 0 | 0.00 % | link |
| PPARG-201 | P37231 | PPARG | Peroxisome proliferator-activated receptor gamma | chr3 | PF00104 | 299 | 486 | Census | Yes | 21 | 35.00 % | 2 | 66.67 % | link |
| PPP1CA-203 | P62136 | PPP1CA | Serine/threonine-protein phosphatase PP1-alpha catalytic subunit | chr11 | PF00149 | 57 | 252 | Not Cancer Driver | No | 17 | 54.84 % | 0 | 0.00 % | link |
| PPP3CA-203 | Q08209 | PPP3CA | Protein phosphatase 3 catalytic subunit alpha | chr4 | PF00149 | 83 | 285 | Compendium | Yes | 19 | 30.16 % | 5 | 71.43 % | link |
| PRKACA-201 | P17612 | PRKACA | cAMP-dependent protein kinase catalytic subunit alpha | chr19 | PF00069 | 44 | 298 | Census | Yes | 46 | 93.88 % | 2 | 100.00 % | link |
| PRMT5-202 | O14744 | PRMT5 | Protein arginine N-methyltransferase 5 | chr14 | PF05185 | 295 | 464 | Not Cancer Driver | No | 16 | 25.81 % | 0 | 0.00 % | link |
| PTBP1-203 | P26599 | PTBP1 | Polypyrimidine tract-binding protein 1 | chr19 | PF00076 | 456 | 521 | Not Cancer Driver | No | 2 | 3.03 % | 0 | 0.00 % | link |
| PTPN13-202 | Q12923 | PTPN13 | Tyrosine-protein phosphatase non-receptor type 13 | chr4 | PF00595 | 1883 | 1961 | Census, Compendium | Yes | 5 | 2.33 % | 0 | 0.00 % | link |
| PTPN18-201 | Q99952 | PTPN18 | Tyrosine-protein phosphatase non-receptor type 18 | chr2 | PF00102 | 56 | 290 | Not Cancer Driver | No | 29 | 69.05 % | 0 | 0.00 % | link |
| PTPN4-201 | P29074 | PTPN4 | Tyrosine-protein phosphatase non-receptor type 4 | chr2 | PF00595 | 517 | 602 | Not Cancer Driver | No | 8 | 7.34 % | 0 | 0.00 % | link |
| RARA-201 | P10276 | RARA | Retinoic acid receptor alpha | chr17 | PF00104 | 224 | 401 | Census, Compendium | Yes | 32 | 53.33 % | 0 | 0.00 % | link |
| RB1-201 | P06400 | RB1 | Retinoblastoma-associated protein | chr13 | PF01857 | 646 | 765 | Census, Compendium | Yes | 19 | 21.35 % | 8 | 38.10 % | link |
| RBBP4-202 | Q09028 | RBBP4 | Histone-binding protein RBBP4 | chr1 | PF12265 | 19 | 88 | Not Cancer Driver | No | 7 | 17.50 % | 0 | 0.00 % | link |
| RBBP4-202 | Q09028 | RBBP4 | Histone-binding protein RBBP4 | chr1 | PF00400 | 364 | 403 | Not Cancer Driver | No | 4 | 10.00 % | 0 | 0.00 % | link |
| RBBP7-203 | Q16576 | RBBP7 | Histone-binding protein RBBP7 | chrX | PF00400 | 363 | 402 | Not Cancer Driver | No | 3 | 7.14 % | 0 | 0.00 % | link |
| RBM17-201 | Q96I25 | RBM17 | Splicing factor 45 | chr10 | PF00076 | 323 | 383 | Not Cancer Driver | No | 5 | 12.20 % | 0 | 0.00 % | link |
| RFXANK-201 | O14593 | RFXANK | DNA-binding protein RFXANK | chr19 | PF00023 | 134 | 243 | Not Cancer Driver | No | 8 | 61.54 % | 1 | 100.00 % | link |
| RIOX1-201 | Q9H6W3 | RIOX1 | Ribosomal oxygenase 1 | chr14 | PF08007 | 215 | 557 | Not Cancer Driver | No | 0 | 0.00 % | 0 | 0.00 % | link |
| RIOX2-203 | Q8IUF8 | RIOX2 | Ribosomal oxygenase 2 | chr3 | PF08007 | 51 | 364 | Not Cancer Driver | No | 23 | 69.70 % | 0 | 0.00 % | link |
| RNF2-202 | Q99496 | RNF2 | E3 ubiquitin-protein ligase RING2 | chr1 | PF16207 | 246 | 330 | Not Cancer Driver | No | 6 | 23.08 % | 0 | 0.00 % | link |
| RNF31-201 | Q96EP0 | RNF31 | E3 ubiquitin-protein ligase RNF31 | chr14 | PF09409 | 69 | 150 | Not Cancer Driver | No | 7 | 6.03 % | 0 | 0.00 % | link |
| RORA-203 | P35398 | RORA | Nuclear receptor ROR-alpha | chr15 | PF00104 | 305 | 494 | Not Cancer Driver | No | 14 | 32.56 % | 2 | 50.00 % | link |
| RORC-201 | P51449 | RORC | Nuclear receptor ROR-gamma | chr1 | PF00104 | 310 | 488 | Not Cancer Driver | No | 23 | 28.40 % | 0 | 0.00 % | link |
| RPL11-206 | P62913 | RPL11 | Large ribosomal subunit protein uL5 | chr1 | PF00281 | 10 | 63 | Not Cancer Driver | No | 6 | 31.58 % | 1 | 100.00 % | link |
| RPRD1B-201 | Q9NQG5 | RPRD1B | Regulation of nuclear pre-mRNA domain-containing protein 1B | chr20 | PF04818 | 7 | 125 | Not Cancer Driver | No | 10 | 43.48 % | 0 | 0.00 % | link |
| RXRA-202 | P19793 | RXRA | Retinoic acid receptor RXR-alpha | chr9 | PF00104 | 257 | 442 | Compendium | Yes | 42 | 60.00 % | 0 | 0.00 % | link |
| S100A10-202 | P60903 | S100A10 | Protein S100-A10 | chr1 | PF01023 | 5 | 44 | Not Cancer Driver | No | 2 | 22.22 % | 0 | 0.00 % | link |
| S100A4-204 | P26447 | S100A4 | Protein S100-A4 | chr1 | PF01023 | 5 | 47 | Not Cancer Driver | No | 1 | 16.67 % | 0 | 0.00 % | link |
| SDCBP-201 | O00560 | SDCBP | Syntenin-1 | chr8 | PF00595 | 198 | 270 | Not Cancer Driver | No | 7 | 30.43 % | 0 | 0.00 % | link |
| SERPINE1-201 | P05121 | SERPINE1 | Plasminogen activator inhibitor 1 | chr7 | PF00079 | 33 | 402 | Not Cancer Driver | No | 55 | 88.71 % | 0 | 0.00 % | link |
| SETD7-201 | Q8WTS6 | SETD7 | Histone-lysine N-methyltransferase SETD7 | chr4 | PF00856 | 170 | 336 | Not Cancer Driver | No | 11 | 42.31 % | 0 | 0.00 % | link |
| SF3B6-201 | Q9Y3B4 | SF3B6 | Splicing factor 3B subunit 6 | chr2 | PF00076 | 21 | 88 | Not Cancer Driver | No | 3 | 42.86 % | 0 | 0.00 % | link |
| SH2D1A-202 | O60880 | SH2D1A | SH2 domain-containing protein 1A | chrX | PF00017 | 6 | 87 | Not Cancer Driver | No | 22 | 78.57 % | 16 | 84.21 % | link |
| SIRT2-201 | Q8IXJ6 | SIRT2 | NAD-dependent protein deacetylase sirtuin-2 | chr19 | PF02146 | 84 | 268 | Not Cancer Driver | No | 21 | 52.50 % | 0 | 0.00 % | link |
| SIRT5-205 | Q9NXA8 | SIRT5 | NAD-dependent protein deacylase sirtuin-5, mitochondrial | chr6 | PF02146 | 58 | 256 | Not Cancer Driver | No | 13 | 59.09 % | 0 | 0.00 % | link |
| SMAD2-201 | Q15796 | SMAD2 | Mothers against decapentaplegic homolog 2 | chr18 | PF03166 | 272 | 443 | Census, Compendium | Yes | 26 | 44.83 % | 2 | 66.67 % | link |
| SMYD2-201 | Q9NRG4 | SMYD2 | N-lysine methyltransferase SMYD2 | chr1 | PF01753 | 52 | 90 | Not Cancer Driver | No | 2 | 7.41 % | 0 | 0.00 % | link |
| SPIRE1-202 | Q08AE8 | SPIRE1 | Protein spire homolog 1 | chr18 | PF16474 | 40 | 236 | Not Cancer Driver | No | 4 | 8.70 % | 0 | 0.00 % | link |
| SPOP-206 | O43791 | SPOP | Speckle-type POZ protein | chr17 | PF00917 | 38 | 163 | Census, Compendium | Yes | 110 | 80.88 % | 5 | 83.33 % | link |
| SPSB1-201 | Q96BD6 | SPSB1 | SPRY domain-containing SOCS box protein 1 | chr1 | PF00622 | 97 | 228 | Not Cancer Driver | No | 14 | 50.00 % | 0 | 0.00 % | link |
| SPSB2-205 | Q99619 | SPSB2 | SPRY domain-containing SOCS box protein 2 | chr12 | PF00622 | 88 | 218 | Not Cancer Driver | No | 18 | 60.00 % | 0 | 0.00 % | link |
| STAMBP-202 | O95630 | STAMBP | STAM-binding protein | chr2 | PF08969 | 8 | 117 | Not Cancer Driver | No | 11 | 25.58 % | 5 | 83.33 % | link |
| STIP1-201 | P31948 | STIP1 | Stress-induced-phosphoprotein 1 | chr11 | PF13181 | 428 | 461 | Not Cancer Driver | No | 4 | 7.41 % | 0 | 0.00 % | link |
| STIP1-201 | P31948 | STIP1 | Stress-induced-phosphoprotein 1 | chr11 | PF00515 | 36 | 69 | Not Cancer Driver | No | 2 | 3.70 % | 0 | 0.00 % | link |
| SUFU-202 | Q9UMX1 | SUFU | Suppressor of fused homolog | chr10 | PF05076 | 64 | 241 | Census | Yes | 14 | 29.17 % | 1 | 50.00 % | link |
| SUMF1-201 | Q8NBK3 | SUMF1 | Formylglycine-generating enzyme | chr3 | PF03781 | 87 | 367 | Not Cancer Driver | No | 20 | 74.07 % | 14 | 93.33 % | link |
| TAX1BP3-201 | O14907 | TAX1BP3 | Tax1-binding protein 3 | chr17 | PF00595 | 17 | 110 | Not Cancer Driver | No | 9 | 75.00 % | 0 | 0.00 % | link |
| TERF2-201 | Q15554 | TERF2 | Telomeric repeat-binding factor 2 | chr16 | PF08558 | 94 | 293 | Not Cancer Driver | No | 10 | 38.46 % | 0 | 0.00 % | link |
| TIAM1-206 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | chr21 | PF00595 | 845 | 925 | Not Cancer Driver | No | 9 | 3.42 % | 0 | 0.00 % | link |
| TJP1-201 | Q07157 | TJP1 | Tight junction protein ZO-1 | chr15 | PF00595 | 422 | 501 | Not Cancer Driver | No | 7 | 4.90 % | 0 | 0.00 % | link |
| TJP1-201 | Q07157 | TJP1 | Tight junction protein ZO-1 | chr15 | PF07653 | 520 | 582 | Not Cancer Driver | No | 2 | 1.40 % | 0 | 0.00 % | link |
| TLE1-203 | Q04724 | TLE1 | Transducin-like enhancer protein 1 | chr9 | PF00400 | 606 | 644 | Not Cancer Driver | No | 8 | 9.20 % | 0 | 0.00 % | link |
| TNKS2-201 | Q9H2K2 | TNKS2 | Poly [ADP-ribose] polymerase tankyrase-2 | chr10 | PF13637 | 679 | 732 | Not Cancer Driver | No | 4 | 4.00 % | 0 | 0.00 % | link |
| TNKS2-201 | Q9H2K2 | TNKS2 | Poly [ADP-ribose] polymerase tankyrase-2 | chr10 | PF12796 | 556 | 622 | Not Cancer Driver | No | 1 | 1.00 % | 0 | 0.00 % | link |
| TNPO1-201 | Q92973 | TNPO1 | Transportin-1 | chr5 | PF03810 | 41 | 109 | Not Cancer Driver | No | 4 | 6.06 % | 0 | 0.00 % | link |
| TP53BP1-201 | Q12888 | TP53BP1 | TP53-binding protein 1 | chr15 | PF09038 | 1483 | 1604 | Not Cancer Driver | No | 8 | 5.03 % | 0 | 0.00 % | link |
| TPST2-201 | O60704 | TPST2 | Protein-tyrosine sulfotransferase 2 | chr22 | PF13469 | 69 | 262 | Not Cancer Driver | No | 23 | 60.53 % | 0 | 0.00 % | link |
| TSG101-201 | Q99816 | TSG101 | Tumor susceptibility gene 101 protein | chr11 | PF05743 | 21 | 141 | Not Cancer Driver | No | 7 | 22.58 % | 0 | 0.00 % | link |
| TYMS-203 | P04818 | TYMS | Thymidylate synthase | chr18 | PF00303 | 31 | 313 | Not Cancer Driver | No | 18 | 100.00 % | 0 | 0.00 % | link |
| UBE2B-201 | P63146 | UBE2B | Ubiquitin-conjugating enzyme E2 B | chr5 | PF00179 | 8 | 145 | Not Cancer Driver | No | 9 | 100.00 % | 0 | 0.00 % | link |
| UHRF1-208 | Q96T88 | UHRF1 | E3 ubiquitin-protein ligase UHRF1 | chr19 | PF00628 | 317 | 366 | Not Cancer Driver | No | 0 | 0.00 % | 0 | 0.00 % | link |
| USP7-201 | Q93009 | USP7 | Ubiquitin carboxyl-terminal hydrolase 7 | chr16 | PF00917 | 74 | 196 | Not Cancer Driver | No | 12 | 8.89 % | 0 | 0.00 % | link |
| VPS4B-201 | O75351 | VPS4B | Vacuolar protein sorting-associated protein 4B | chr18 | PF04212 | 8 | 74 | Not Cancer Driver | No | 4 | 12.12 % | 0 | 0.00 % | link |
| VTA1-202 | Q9NP79 | VTA1 | Vacuolar protein sorting-associated protein VTA1 homolog | chr6 | PF04652 | 16 | 158 | Not Cancer Driver | No | 15 | 45.45 % | 0 | 0.00 % | link |
| WDR5-201 | P61964 | WDR5 | WD repeat-containing protein 5 | chr9 | PF00400 | 291 | 331 | Not Cancer Driver | No | 5 | 27.78 % | 0 | 0.00 % | link |
| YWHAZ-207 | P63104 | YWHAZ | 14-3-3 protein zeta/delta | chr8 | PF00244 | 9 | 229 | Not Cancer Driver | No | 17 | 89.47 % | 0 | 0.00 % | link |